Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers

Kiran Shekar, Jenelle Badulak, Giles Peek, Udo Boeken, Heidi J Dalton, Lovkesh Arora, Bishoy Zakhary, Kollengode Ramanathan, Joanne Starr, Bindu Akkanti, M Velia Antonini, Mark T Ogino, Lakshmi Raman, Nicholas Barret, Daniel Brodie, Alain Combes, Roberto Lorusso, Graeme MacLaren, Thomas Müller, Matthew Paden, Vincent Pellegrino, ELSO Guideline Working Group, Kiran Shekar, Jenelle Badulak, Giles Peek, Udo Boeken, Heidi J Dalton, Lovkesh Arora, Bishoy Zakhary, Kollengode Ramanathan, Joanne Starr, Bindu Akkanti, M Velia Antonini, Mark T Ogino, Lakshmi Raman, Nicholas Barret, Daniel Brodie, Alain Combes, Roberto Lorusso, Graeme MacLaren, Thomas Müller, Matthew Paden, Vincent Pellegrino, ELSO Guideline Working Group

Abstract

Disclaimer: The Extracorporeal Life Support Organization (ELSO) Coronavirus Disease 2019 (COVID-19) Guidelines have been developed to assist existing extracorporeal membrane oxygenation (ECMO) centers to prepare and plan provision of ECMO during the ongoing pandemic. The recommendations have been put together by a team of interdisciplinary ECMO providers from around the world. Recommendations are based on available evidence, existing best practice guidelines, ethical principles, and expert opinion. This is a living document and will be regularly updated when new information becomes available. ELSO is not liable for the accuracy or completeness of the information in this document. These guidelines are not meant to replace sound clinical judgment or specialist consultation but rather to strengthen provision and clinical management of ECMO specifically, in the context of the COVID-19 pandemic.

Conflict of interest statement

Disclosure: Dr. Dalton receives funding from innovative extracorporeal membrane oxygenation (ECMO) concepts. The remaining authors have no conflicts of interest to report.

Figures

Figure 1.
Figure 1.
Key considerations on which these guidelines are based.
Figure 2.
Figure 2.
ECMO provision based on system capacity. COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ECPR, extracorporeal cardiopulmonary resuscitation; ICU, intensive care unit; VA, venoarterial; VV, venovenous.
Figure 3.
Figure 3.
Conventional VV indications for ARDS. ARDS, acute respiratory distress syndrome; ECMO, extracorporeal membrane oxygenation; FiO2, fraction of inspired oxygen; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen; PEEP, positive end-expiratory pressure; VV, venovenous.
Figure 4.
Figure 4.
Summary of patient management on ECMO. ARDS, acute respiratory distress syndrome; bpm, beats per minute; COVID-19, coronavirus disease 2019; CS, cardiogenic shock; CT, computed tomography; DVT, deep venous thrombosis; ECMO, extracorporeal membrane oxygenation; FiO2, fraction of inspired oxygen; Hb, hemoglobin; IVC, inferior vena cava; MV, mechanical ventilation; PD, pharmacodynamics; PEEP, positive end-expiratory pressure; PK, pharmacokinetics; PLT, platelets; PPE, personal protective equipment; PPLAT, plateau pressure; PT, physiotherapy; RCT, randomized controlled trial; RR, respiratory rate; SpO2, peripheral saturation of oxygen; XR, x-rays.

References

    1. Available at: . Accessed April 12, 2020.
    1. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response. JAMA 2020. [Epub ahead of print]
    1. Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020. [Epub ahead of print]
    1. Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020. [Epub ahead of print]
    1. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med 2020. [Epub ahead of print]
    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. [Epub ahead of print]
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020395: 497–506.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 10, 2020.
    1. Available at: . Accessed April 07, 2020.
    1. Ramanathan K, Antognini D, Combes A, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med 2020. [Epub ahead of print]
    1. Combes A, Hajage D, Capellier G, et al. EOLIA Trial Group, REVA, and ECMONet ; EOLIA Trial Group, REVA, and ECMONet Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018378: 1965–1975.
    1. Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA 2018320: 2251–2259.
    1. Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A systematic review and meta-analysis. Lancet Respir Med 20197: 163–172.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 07, 2020.
    1. Alhazzani W, Moller MH, Arabi YM, et al. Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020. [Epub ahead of print]
    1. Bartlett RH, Ogino MT, Brodie D, et al. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J 202066: 472–474.
    1. Available at: . Accessed April 08, 2020.
    1. Available at: . Accessed April 08, 2020.
    1. Available at: . Accessed April 08, 2020.
    1. DellaVolpe J, Barbaro RP, Cannon JW, et al. Joint Society of Critical Care Medicine-Extracorporeal Life Support Organization Task Force position paper on the role of the intensivist in the initiation and management of extracorporeal membrane oxygenation. Crit Care Med 2020. [Epub ahead of print]
    1. Zangrillo A, Biondi-Zoccai G, Landoni G, et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: A systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care 201317: R30.
    1. Sukhal S, Sethi J, Ganesh M, Villablanca PA, Malhotra AK, Ramakrishna H. Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis. Ann Card Anaesth 201720: 14–21.
    1. Alshahrani MS, Sindi A, Alshamsi F, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care 20188: 3.
    1. Al Gazwi HA, Ibrahim EE, Al Hammad ZA, Robeh ZA. Extracorporeal membrane oxygenation in severe ARDS secondary to Middle East respiratory syndrome coronavirus. Respiratory Care 201964(suppl 10): 3223338.
    1. Available at: . Accessed April 07, 2020.
    1. Tabery J, Mackett CW., III University of Pittsburgh Medical Center Pandemic Influenza Task Force’s Triage Review Board ; University of Pittsburgh Medical Center Pandemic Influenza Task Force’s Triage Review Board Ethics of triage in the event of an influenza pandemic. Disaster Med Public Health Prep 20082: 114–118.
    1. Christian MD, Sprung CL, King MA, et al. Task Force for Mass Critical Care; Task Force for Mass Critical Care ; Task Force for Mass Critical Care; Task Force for Mass Critical Care Triage: Care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest 2014146(4 suppl): e61S–e74S.
    1. Abrams D, Pham T, Burns KEA, et al. International ECMO Network (ECMONet) ; International ECMO Network (ECMONet) Practice patterns and ethical considerations in the management of venovenous extracorporeal membrane oxygenation patients: An international survey. Crit Care Med 201947: 1346–1355.
    1. Abrams DC, Prager K, Blinderman CD, Burkart KM, Brodie D. Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. Chest 2014145: 876–882.
    1. Bein T, Brodie D. Understanding ethical decisions for patients on extracorporeal life support. Intensive Care Med 201743: 1510–1511.
    1. Brodie D, Curtis JR, Vincent JL, et al. participants in the Round Table Conference ; participants in the Round Table Conference Treatment limitations in the era of ECMO. Lancet Respir Med 20175: 769–770.
    1. Combes A, Brodie D, Bartlett R, et al. International ECMO Network (ECMONet) ; International ECMO Network (ECMONet) Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 2014190: 488–496.
    1. Abrams D, Garan AR, Abdelbary A, et al. International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO) ; International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO) Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med 201844: 717–729.
    1. Available at: . Accessed April 07, 2020.
    1. MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: The potential role of extracorporeal membrane oxygenation. JAMA 2020. [Epub ahead of print]
    1. Hick J, Barbera J, Kelen G. Refining surge capacity: Conventional, contingency, and crisis capacity. Disaster Med Public Health Prep 20093(2 suppl): S59–S67.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 12, 2020.
    1. Available at: . Accessed April 10, 2020.
    1. Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: A review. JAMA 2019322: 557–568.
    1. Gattinoni L, Coppola S, Cressoni M, Busana M, Chiumello D. Covid-19 does not lead to a “Typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 2020. [Epub ahead of print]
    1. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: Different respiratory treatment for different phenotypes? Intensive Care Med 2020. [Epub ahead of print]
    1. Schmidt M, Pham T, Arcadipane A, et al. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort. Am J Respir Crit Care Med 2019200: 1002–1012.
    1. Clerkin KJ, Fried JA, Raikhelkar J, et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation 2020. [Epub ahead of print]
    1. Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation 2020. [Epub ahead of print]
    1. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 202075: 2352–2371.
    1. Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020. [Epub ahead of print]
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020395: 1054–1062.
    1. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020382: e38.
    1. Xie Y, Wang X, Yang P, Zhang S. COVID-19 complicated by acute pulmonary embolism. Radiology: Cardiothoracic Imaging 20202: e200067.
    1. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: A random association? Eur Heart J 2020. [Epub ahead of print]
    1. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020. [Epub ahead of print]
    1. Available at: . Accessed April 07, 2020.
    1. Reyentovich A, Barghash MH, Hochman JS. Management of refractory cardiogenic shock. Nat Rev Cardiol 201613: 481–492.
    1. Broman LM, Taccone FS, Lorusso R, et al. The ELSO Maastricht Treaty for ECLS Nomenclature: Abbreviations for cannulation configuration in extracorporeal life support - a position paper of the Extracorporeal Life Support Organization. Crit Care 201923: 36.
    1. Shao F, Xu S, Ma X, et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation 2020151: 18–23.
    1. Schmidt M, Bailey M, Sheldrake J, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med 2014189: 1374–1382.
    1. Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: The survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J 201536: 2246–2256.
    1. Schmidt M, Zogheib E, Rozé H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 201339: 1704–1713.
    1. Available at: . Accessed April 07, 2020.
    1. Platts DG, Sedgwick JF, Burstow DJ, Mullany DV, Fraser JF. The role of echocardiography in the management of patients supported by extracorporeal membrane oxygenation. J Am Soc Echocardiogr 201225: 131–141.
    1. Phua J, Weng L, Ling L, et al. Asian Critical Care Clinical Trials Group ; Asian Critical Care Clinical Trials Group Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations. Lancet Respir Med 20208: 506–517.
    1. Liew MF, Siow WT, MacLaren G, See KC. Preparing for COVID-19: Early experience from an intensive care unit in Singapore. Crit Care 202024: 83.
    1. Arabi YM, Fowler R, Hayden FG. Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Med 202046: 315–328.
    1. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000342: 1301–1308.
    1. Abrams D, Schmidt M, Pham T, et al. Mechanical ventilation for acute respiratory distress syndrome during extracorporeal life support. Research and practice. Am J Respir Crit Care Med 2020201: 514–525.
    1. Peek GJ, Mugford M, Tiruvoipati R, et al. CESAR trial collaboration ; CESAR trial collaboration Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 2009374: 1351–1363.
    1. Available at: . Accessed April 07, 2020.
    1. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. HLH Across Speciality Collaboration, UK ; HLH Across Speciality Collaboration, UK COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020395: 1033–1034.
    1. Agerstrand CL, Burkart KM, Abrams DC, Bacchetta MD, Brodie D. Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome. Ann Thorac Surg 201599: 590–595.
    1. Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A 2020117: 9490–9496.
    1. Lambell KJ, Tatucu-Babet OA, Chapple LA, Gantner D, Ridley EJ. Nutrition therapy in critical illness: A review of the literature for clinicians. Crit Care 202024: 35.
    1. Available at: . Accessed April 10, 2020.
    1. Available at: . Accessed April 10, 2020.
    1. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020105949.
    1. Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020382: 1787–1799.
    1. Roberts JA. Using PK/PD to optimize antibiotic dosing for critically ill patients. Curr Pharm Biotechnol 201112: 2070–2079.
    1. Varghese JM, Roberts JA, Lipman J. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin 201127: 19–34.
    1. Shekar K, Fraser JF, Smith MT, Roberts JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care 201227: 741.e9–e18.
    1. Shekar K, Roberts JA, Mcdonald CI, et al. Sequestration of drugs in the cicuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care 201216: R194.
    1. Shekar K, Roberts JA, Mcdonald CI, et al. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: Results from an ex vivo study. Crit Care 201519: 164.
    1. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020. [Epub ahead of print]
    1. Arabi YM, Mandourah Y, Al-Hameed F, et al. Saudi Critical Care Trial Group ; Saudi Critical Care Trial Group Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med 2018197: 757–767.
    1. Datzmann T, Träger K. Extracorporeal membrane oxygenation and cytokine adsorption. J Thorac Dis 201810(suppl 5): S653–S660.
    1. Abrams D, Javidfar J, Farrand E, et al. Early mobilization of patients receiving extracorporeal membrane oxygenation: A retrospective cohort study. Crit Care 201418: R38.
    1. Bull T, Corley A, Lye I, Spooner AJ, Fraser JF. Cannula and circuit management in peripheral extracorporeal membrane oxygenation: An international survey of 45 countries. PLoS One 201914: e0227248.
    1. Vasques F, Romitti F, Gattinoni L, Camporota L. How I wean patients from veno-venous extra-corporeal membrane oxygenation. Crit Care 201923: 316.
    1. Broman LM, Malfertheiner MV, Montisci A, Pappalardo F. Weaning from veno-venous extracorporeal membrane oxygenation: How I do it. J Thorac Dis 201810(suppl 5): S692–S697.
    1. Aissaoui N, Luyt CE, Leprince P, et al. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med 201137: 1738–1745.
    1. Liew MF, Siow WT, Yau YW, See KC. Safe patient transport for COVID-19. Crit Care 202024: 94.
    1. Lahner D, Nikolic A, Marhofer P, et al. Incidence of complications in intrahospital transport of critically ill patients–experience in an Austrian university hospital. Wien Klin Wochenschr 2007119: 412–416.
    1. Reddy SC, Valderrama AL, Kuhar DT. Improving the use of personal protective equipment: Applying lessons learned. Clin Infect Dis 201969(suppl 3): S165–S170.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 07, 2020.
    1. Available at: . Accessed April 07, 2020.
    1. Chen X, Tian J, Li G, Li G. Initiation of a new infection control system for the COVID-19 outbreak. Lancet Infect Dis 202020: 397–398.
    1. Available at: . Accessed April 07, 2020.
    1. Statement on COVID-19: Ethical Considerations from a Global Perspective. Statement of the UNESCO International Bioethics Committee (IBC) and the UNESCO World Commission on the Ethics of Scientific Knowledge and Technology (COMEST). Available at: . Accessed April 09, 2020.
    1. Available at: . Accessed April 07, 2020.

Source: PubMed

3
구독하다